Suppr超能文献

2型糖尿病患者的下丘脑-垂体-肾上腺活动:自主神经失衡的作用。

Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance.

作者信息

Chiodini Iacopo, Di Lembo Sergio, Morelli Valentina, Epaminonda Paolo, Coletti Francesca, Masserini Benedetta, Scillitani Alfredo, Arosio Maura, Adda Guido

机构信息

Department of Endocrinology, San Giuseppe-Fatebenefratelli Hospital, A.Fa.R., 20123 Milan, Italy.

出版信息

Metabolism. 2006 Aug;55(8):1135-40. doi: 10.1016/j.metabol.2006.04.010.

Abstract

Symptomatic diabetic neuropathy has been found to be associated with hypothalamus-pituitary-adrenal (HPA) axis hyperfunction, but no data are available about HPA activity in diabetic patients with asymptomatic autonomic imbalance. To evaluate HPA axis activity in patients with type 2 diabetes mellitus (T2DM) in relation to the presence or the absence of subclinical parasympathetic or sympathetic neuronal dysfunction, we performed an observational study on 59 consecutive type 2 diabetic patients without chronic complications and/or symptoms of neuropathy or hypercortisolism. The following were measured: serum cortisol at 08:00 am and at midnight (F8 and F24, respectively), post-dexamethasone suppression cortisol, 24-hour urinary free cortisol (UFC), and morning corticotropin (ACTH). Deep-breathing (DB) and LS (LS) autonomic tests were performed to assess the parasympathetic function; postural hypotension test was performed to evaluate sympathetic activity. Patients were subdivided into 4 groups: subjects with parasympathetic failure (group A), sympathetic failure (group B), both para- and sympathetic failure (group C), and without autonomic failure (group D). Hypothalamus-pituitary-adrenal activity was increased in group A compared with group D (UFC, 48.6 +/- 21.4 vs 21.6 +/- 9.8 microg/24 h, P < .0001; ACTH, 27.0 +/- 8.6 vs 15.7 +/- 5.7 pg/dL, P < .01; F8, 20.4 +/- 4.5 vs 13.6 +/- 3.8 microg/dL, P < .05; post-dexamethasone suppression cortisol, 1.2 +/- 0.4 vs 0.8 +/- 0.6 microg/dL, P < .05, respectively) and group B (UFC, 26.3 +/- 11.0 microg/24 h, P < .0001; ACTH, 19.9 +/- 8.0 pg/dL, P < .05). Regression analysis showed that UFC levels were significantly associated with the deep-breathing test (beta = -0.40, P = .004) and tended to be associated with the lying-to-standing test (beta = -0.26, P = .065), whereas body mass index, glycated hemoglobin, and duration of disease were not. Type 2 diabetic patients with asymptomatic parasympathetic derangement have increased activity of HPA axis, related to the degree of the neuronal dysfunction.

摘要

已发现有症状的糖尿病神经病变与下丘脑 - 垂体 - 肾上腺(HPA)轴功能亢进有关,但关于无症状自主神经失衡的糖尿病患者的HPA活性尚无数据。为了评估2型糖尿病(T2DM)患者中HPA轴活性与亚临床副交感神经或交感神经神经元功能障碍的有无之间的关系,我们对59例无慢性并发症和/或神经病变或皮质醇增多症症状的连续2型糖尿病患者进行了一项观察性研究。测量了以下指标:上午8点和午夜的血清皮质醇(分别为F8和F24)、地塞米松抑制后皮质醇、24小时尿游离皮质醇(UFC)和早晨促肾上腺皮质激素(ACTH)。进行深呼吸(DB)和LS(LS)自主神经测试以评估副交感神经功能;进行体位性低血压测试以评估交感神经活动。患者被分为4组:副交感神经功能衰竭组(A组)、交感神经功能衰竭组(B组)、副交感和交感神经功能均衰竭组(C组)以及无自主神经功能衰竭组(D组)。与D组相比,A组的下丘脑 - 垂体 - 肾上腺活性增加(UFC,48.6±21.4 vs 21.6±9.8μg/24 h,P <.0001;ACTH,27.0±8.6 vs 15.7±5.7 pg/dL,P <.01;F8,20.4±4.5 vs 13.6±3.8μg/dL,P <.05;地塞米松抑制后皮质醇,1.2±0.4 vs 0.8±0.6μg/dL,P <.05),与B组相比也增加(UFC,26.3±11.0μg/24 h,P <.0001;ACTH,19.9±8.0 pg/dL,P <.05)。回归分析表明,UFC水平与深呼吸测试显著相关(β = -0.40,P =.004),并且倾向于与卧立位测试相关(β = -0.26,P =.065),而体重指数、糖化血红蛋白和病程则无关。无症状副交感神经紊乱的2型糖尿病患者的HPA轴活性增加,与神经元功能障碍的程度有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验